Cipla Gx

Analyse Et Revue Des Applications Android: Cipla Gx, Développée Par Cipla Digital. Inscrit Dans La Catégorie Médecine. La Version Actuelle Est 0.1.0, Mise À Jour Le 03/06/2019 . Selon Les Avis Des Utilisateurs Sur Google Play: Cipla Gx. Atteint Plus De 25 Mille Installations. Cipla Gx A Actuellement 199 Revues, Note Moyenne 3.8 Étoiles

Cipla Gx is built for Pharma retailers and stockists.

This application completely covers the entire product range under Cipla Generics division.
Cipla Gx is free to download from the App store and works offline and does not require any internet connection once downloaded.

Features:-
1. The app displays the complete product details like: Brand name, Pack size, Dosage and Therapeutic category along with the product snap.
2. You can search various products by typing the Brand name, generic name, therapeutic category.
3. The app also allows you to add products to your favourite lists for ready reference.
4. The app is simple to use and navigate.
5. Cipla Gx will provide you all the information pertaining to its Generics (Gx) division on the go.

We shall keep adding new features to this app and make it more user-friendly and informative.

About Cipla:

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Our portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.Cipla's turnover in FY 2013-14 was 1.7 billion USD.

Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla's emphasis on access for patients was recognized globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than one dollar a day and thereby treating many millions of patients since 2001.

Cipla's research and development focuses on developing innovative products and drug delivery systems and has given India and the world many 'firsts' for instance Triomune. In a tightly regulated environment, the company's manufacturing facilities have approvals from all the main regulators including USFDA, UKMHRA, WHO, MCC, ANVISA, and PMDA which means the company provides one universal standard both domestically and internationally.

Read more